Trademark: 97084291
Word
GEFRELEZ
Status
Registered
Status Code
700
Status Date
Tuesday, November 22, 2022
Serial Number
97084291
Registration Number
6905448
Registration Date
Tuesday, November 22, 2022
Mark Type
4000
Filing Date
Wednesday, October 20, 2021
Published for Opposition
Tuesday, September 6, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
The wording GEFRELEZ has no meaning in a foreign language.

Trademark Events
Nov 22, 2022
Notice Of Registration Confirmation Emailed
Nov 22, 2022
Registered-Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 6, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 6, 2022
Published For Opposition
Aug 17, 2022
Notification Of Notice Of Publication E-Mailed
Jul 29, 2022
Approved For Pub - Principal Register
Jul 29, 2022
Examiner's Amendment Entered
Jul 29, 2022
Notification Of Examiners Amendment E-Mailed
Jul 29, 2022
Examiners Amendment E-Mailed
Jul 29, 2022
Examiners Amendment -Written
Jul 26, 2022
Notification Of Non-Final Action E-Mailed
Jul 26, 2022
Non-Final Action E-Mailed
Jul 26, 2022
Non-Final Action Written
Jul 26, 2022
Assigned To Examiner
Nov 7, 2021
New Application Office Supplied Data Entered In Tram
Oct 23, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24